Age-Related Macular Degeneration (AMD) - Beta Study Telemedicine Assessment
Completed
- Conditions
- Age-Related Macular Degeneration
- Registration Number
- NCT01083147
- Lead Sponsor
- Notal Vision Ltd.
- Brief Summary
The purpose of this study is to evaluate the compliance of the Foresee Home device in intermediate AMD patients.
- Detailed Description
This is a non-randomized cohort, multi-center study. The eligible subjects will be asked to use the FORESEE HOME device daily and the tests results will be automatically transmitted to the Data Monitor Center for analysis.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
- Subjects who successfully completed participation in ForeseeHome-US2 study
- Patients with ability to comprehend and sign the informed consent/authorization
Exclusion Criteria
- Subjects who failed to complete participation in ForeseeHome-US2 study
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Subject compliance with Foresee HomeTM device 6 months
- Secondary Outcome Measures
Name Time Method Assessment of the Telemedicine infrastructure 6 months
Trial Locations
- Locations (1)
Vitreos retina center
🇺🇸Tom's river, New Jersey, United States
Vitreos retina center🇺🇸Tom's river, New Jersey, United States